Autism Spectrum Disorder Trial, Recruiting (NCT06659731)

Autism Spectrum Disorder Trial, Recruiting NCT06659731 Sponsor: IRCCS Eugenio Medea Condition: Autism Spectrum Disorder

Printed from Voxsanity (voxsanity.com.au) — NCT06659731 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Autism Spectrum Disorder

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Clinical group (children with autism):

Children and teenagers between 5 and 17 years old
A diagnosis of autism based on DSM-5 criteria

Control group (children without diagnoses):

Children and teenagers between 5 and 17 years old who are healthy and have no neurological or psychiatric diagnoses

Who may not be able to join:

Children who have been diagnosed with a peripheral nerve condition (a problem affecting the nerves outside the brain and spinal cord)
Children who have a psychiatric diagnosis such as psychosis
Children who have Tourette Syndrome
Children who have a neurological condition such as epilepsy
Children who have a sensory impairment or loss (such as significant vision or hearing problems)
Children who have a genetic condition or syndrome

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0039 3200598331

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06659731

Sponsor: IRCCS Eugenio Medea

Phase: Not Applicable

Status: Recruiting

Condition: Autism Spectrum Disorder

Trial contact: 0039 3200598331

More information: https://clinicaltrials.gov/study/NCT06659731

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Clinical group (children with autism):

Children and teenagers between 5 and 17 years old
A diagnosis of autism based on DSM-5 criteria

Control group (children without diagnoses):

Children and teenagers between 5 and 17 years old who are healthy and have no neurological or psychiatric diagnoses

Who may not be able to join:

Children who have been diagnosed with a peripheral nerve condition (a problem affecting the nerves outside the brain and spinal cord)
Children who have a psychiatric diagnosis such as psychosis
Children who have Tourette Syndrome
Children who have a neurological condition such as epilepsy
Children who have a sensory impairment or loss (such as significant vision or hearing problems)
Children who have a genetic condition or syndrome

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

IRCCS Eugenio Medea

Registry

ClinicalTrials.gov

Start date

17 July 2024

Est. completion

1 July 2025

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

EEG responses in the time domain; Cold detection threshold; Warm detection threshold; Cold pain threshold; Warm pain threshold; Mechanical detection threshold; Mechanical pain threshold; Vibration detection threshold; Pressure pain threshold; EEG responses in the time-frequency domain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov